4,509
Views
57
CrossRef citations to date
0
Altmetric
Review

Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment

, , , &
Pages 817-830 | Received 29 Dec 2017, Accepted 31 Jan 2018, Published online: 06 Feb 2018

References

  • Tessmer MS, Anderson KC. AACR cancer progress report 2016: improving lives through research. Clin Cancer Res. 2016;22:4759.
  • Gidwani B, Vyas A. The potentials of nanotechnology-based drug delivery system for treatment of ovarian cancer. Artif Cell Nanomed B. 2015;43:291–297.
  • Lin J, Wang SJ, Huang P, et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano. 2013;7:5320–5329.
  • Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387.
  • Thangavel S, Yoshitomi T, Sakharkar MK, et al. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects. Biomaterials. 2016;99:109–123.
  • Wu L, Fang ST, Shi S, et al. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study. Biomacromolecules. 2013;14:3027–3033.
  • Li M, Deng H, Peng H. Functional nanoparticles in targeting glioma diagnosis and therapies. J Nanosci Nanotechnol. 2014;14:415–432.
  • Kanapathipillai M, Brock A, Ingber DE. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv Drug Deliv Rev. 2016;26:107–118.
  • Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci. 2015;39:268–307.
  • Maeda H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. 2015;91:3–6.
  • Safdar MH, Hussai Z, Abourehab MAS, et al. New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumor-specific targetability and improved anticancer efficacy. Artif Cells Nanomed Biotechnol. 2017 [cited 2017 Oct 30]; [14 p.]. DOI:https://doi.org/10.1080/21691401.2017.1397001
  • Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. Ca Cancer J Clin. 2011;61:250–281.
  • Kamkaew A, Lim SH, Lee HB, et al. BODIPY dyes in photodynamic therapy. Chem Soc Rev. 2013;42:77.
  • Nishiyama N, Nakagishi Y, Morimoto Y, et al. Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J Control Release. 2009;133:245–251.
  • Liang X, Li X, Yue X, et al. Conjugation of porphyrin to nanohybrid cerasomes for photodynamic diagnosis and therapy of cancer. Angew Chem. 2011;123:11826–11831.
  • Fan L, Zhao SS, Jin X, et al. Synergistic chemo-photodynamic therapy by “big & small combo nanoparticles” sequential release system. Nanomedicine. 2017;14:109–121.
  • Fan L, Jin B, Zhang S, et al. Stimuli-free programmable drug release for combination chemo-therapy. Nanoscale. 2016;8:12553–12559.
  • Feng XY, Jiang D, Kang T, et al. Tumor-homing and penetrating peptide-functionalized photosensitizer-conjugated PEG-PLA nanoparticles for chemo-photodynamic combination therapy of drug-resistant cancer. ACS Appl Mater Interfaces. 2016;8:17817–17832.
  • Zhou FF, Wu SN, Wu BY, et al. Mitochondria-targeting single-walled carbon nanotubes for cancer photothermal therapy. Small. 2011;7:2727–2735.
  • Vivero-Escoto JL, Huxford-Phillips RC, Lin W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem Soc Rev. 2012;41:2673–2685.
  • Makhadmeh GN, Aziz AA, Razak KA. The efficacy of methylene blue encapsulated in silica nanoparticles compared to naked methylene blue for photodynamic applications. Artif Cell Nanomed B. 2016;44:1018–1022.
  • Liu JT, Zhang L, Lei JP, et al. Multifunctional metal − organic framework nanoprobe for cathepsin b-activated cancer cell imaging and chemo-photodynamic therapy. ACS Appl Mater Interfaces. 2017;9:2150–2158.
  • Yang GB, Xu LG, Chao Y, et al. Hollow MnO2 as a tumor-microenvironment responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun. 2017;8:902.
  • Dong CH, Liu ZY, Wang S, et al. A protein − polymer bioconjugate-coated upconversion nanosystem for simultaneous tumor cell imaging, photodynamic therapy, and chemotherapy. ACS Appl Mater Interfaces. 2016;8:32688–32698.
  • Yuan YY, Liu J, Liu B. Conjugated-polyelectrolyte-based polyprodrug: targeted and image- guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source. Angew Chem Int Ed. 2014;53:7163–7168.
  • Yue CX, Zhang CL, Alfranca G, et al. Near-infrared light triggered ROS-activated theranostic platform based on Ce6-CPT-UCNPs for simultaneous fluorescence imaging and chemo-photodynamic combined therapy. Theranostics. 2016;6:456–469.
  • Cai HJ, Shen TT, Kirillov AM, et al. Self-assembled upconversion nanoparticle clusters for NIR-controlled drug release and synergistic therapy after conjugation with gold nanoparticles. Inorg Chem. 2017;56:5295–5304.
  • Feng LZ, Cheng L, Dong ZL, et al. Theranostic liposomes with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy. ACS Nano. 2017;11:927–937.
  • Feng LL, Gai SL, He F, et al. Multifunctional mesoporous ZrO2 encapsulated upconversion nanoparticles for mild NIR light activated synergistic cancer therapy. Biomaterials. 2017;147:39–52.
  • Zhao N, Wu BY, Hu XL, et al. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles. Biomaterials. 2017; 141:40–49.
  • Wang HR, Zhu WW, Feng LZ, et al. Nanoscale covalent organic polymers as a biodegradable nanomedicine for chemotherapy-enhanced photodynamic therapy of cancer. Nano Res. 2017. DOI:https://doi.org/10.1007/s12274-017-1858-y
  • Zhang YM, Huang F, Ren CH, et al. Targeted chemo-photodynamic combination platform based on the DOX prodrug nanoparticles for enhanced cancer therapy. ACS Appl Mater Interfaces. 2017;9:13016–13028.
  • Wan H, Zhang Y, Zhang W, et al. Robust two-photon visualized nanocarrier with dual targeting ability for controlled chemo-photodynamic synergistic treatment of cancer. ACS Appl Mater Interfaces. 2015;7:9608–9618.
  • Li XM, Zhang F, Zhao DY. Lab on upconversion nanoparticles: optical properties and applications engineering via designed nanostructure. Chem Soc Rev. 2015;44:1346–1378.
  • Lehár J, Krueger AS, Avery W, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009; 27:659.
  • Li ZL, Liu J, Hu Y, et al. Multimodal imaging-guided antitumor photothermal therapy and drug delivery using bismuth selenide spherical-sponge. ACS Nano. 2016;10:9646–9658.
  • Chen Q, Ke HT, Dai ZF, et al. Nanoscale theranostics for physical stimulus-responsive cancer therapies. Biomaterials. 2015;73:214–230.
  • Song X, Chen Q, Liu Z. Recent advances in the development of organic photothermal nano-agents. Nano Res. 2014;8:340–354.
  • Bradley EC, Barr JW. Determination of blood volume using indocyanine green (cardio-green) dye. Life Sci. 1968;7:1001–1007.
  • Chen Y, Li HH, Deng YY, et al. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Acta Biomater. 2017;51:374–392.
  • Li FY, Yang H, Bie NN, et al. Temperature/redox-sensitive nanogels for near-infrared light-triggered synergistic thermo-chemotherapy. ACS Appl Mater Interfaces. 2017;9:23564–23573.
  • Chen Q, Liang C, Wang C, et al. An imagable and photothermal “Abraxanelike” nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors. Adv Mater. 2014;27:903–910.
  • Cao J, Huang SS, Chen YQ, et al. Near-infrared light-triggered micelles for fast controlled drug release in deep tissue. Biomaterials. 2013;34:6272–6283.
  • Cao J, Chen D, Huang SS, et al. Multifunctional near-infrared light-triggered biodegradable micelles for chemo- and photo-thermal combination therapy. Oncotarget. 2016;7:82170–82184.
  • Li YL, Deng YB, Tian X, et al. Multipronged design of light-triggered nanoparticles to overcome cisplatin resistance for efficient ablation of resistant tumor. ACS Nano. 2015;9:9626–9637.
  • Shen S, Tang H, Zhang X, et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials. 2013;34:3150–3158.
  • Liu YW, Bai J, Jia XD, et al. Fabrication of multifunctional SiO2@GN-serum composites for chemo-photothermal synergistic therapy. ACS Appl Mater Interfaces. 2015;7:112–121.
  • Deng Y, Huang L, Yang H, et al. Cyanine-anchored silica nanochannels for light-driven synergistic thermo-chemotherapy. Small. 2017;13:1602747.
  • Liu J, Wang C, Wang X, et al. Mesoporous silica coated single-walled carbon nanotubes as a multifunctional light-responsive platform for cancer combination therapy. Adv Funct Mater. 2015;25:384–392.
  • Park H, Yang J, Lee J, et al. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano. 2009;3:2919–2926.
  • Xia B, Wang B, Shi JS, et al. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer. Acta Biomater. 2017;51:197–208.
  • Gong H, Cheng L, Xiang J, et al. Near-infrared absorbing polymeric nanoparticles as a versatile drug carrier for cancer combination therapy. Adv Funct Mater. 2013;23:6059–6067.
  • Feng QH, Zhang YY, Zhang WX, et al. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy. Acta Biomater. 2017;49:402–413.
  • Park H, Kim J, Jung S, et al. DNA-Au nanomachine equipped with i-motif and G-quadruplex for triple combinatorial anti-tumor therapy. Adv Funct Mater. 2018;28:1705416.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.